194 related articles for article (PubMed ID: 25375241)
41. Comparison of checkpoint responses triggered by DNA polymerase inhibition versus DNA damaging agents.
Liu JS; Kuo SR; Melendy T
Mutat Res; 2003 Nov; 532(1-2):215-26. PubMed ID: 14643438
[TBL] [Abstract][Full Text] [Related]
42. TAp73 induction by nitric oxide: regulation by checkpoint kinase 1 (CHK1) and protection against apoptosis.
Tebbi A; Guittet O; Cottet MH; Vesin MF; Lepoivre M
J Biol Chem; 2011 Mar; 286(10):7873-7884. PubMed ID: 21212274
[TBL] [Abstract][Full Text] [Related]
43. Cancer Fighting SiRNA-RRM2 Loaded Nanorobots.
Sharma A; Kumar P; Ambasta RK
Pharm Nanotechnol; 2020; 8(2):79-90. PubMed ID: 32003677
[TBL] [Abstract][Full Text] [Related]
44. A novel mechanism of checkpoint abrogation conferred by Chk1 downregulation.
Xiao Z; Xue J; Sowin TJ; Rosenberg SH; Zhang H
Oncogene; 2005 Feb; 24(8):1403-11. PubMed ID: 15608676
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of Ribonucleotide Reductase Subunit M2 Enhances the Radiosensitivity of Metastatic Pancreatic Neuroendocrine Tumor.
Chow Z; Johnson J; Chauhan A; Jeong JC; Castle JT; Izumi T; Weiss H; Townsend CM; Schrader J; Anthony L; Yang ES; Evers BM; Rychahou P
Cancer Lett; 2024 May; ():216993. PubMed ID: 38801884
[TBL] [Abstract][Full Text] [Related]
46. Dissecting cellular responses to irradiation via targeted disruptions of the ATM-CHK1-PP2A circuit.
Palii SS; Cui Y; Innes CL; Paules RS
Cell Cycle; 2013 Apr; 12(7):1105-18. PubMed ID: 23462183
[TBL] [Abstract][Full Text] [Related]
47. Bone marrow ribonucleotide reductase mRNA levels and methylation status as prognostic factors in patients with myelodysplastic syndrome treated with 5-Azacytidine.
Kontandreopoulou CN; Diamantopoulos PT; Giannopoulos A; Symeonidis A; Kotsianidis I; Pappa V; Galanopoulos A; Panayiotidis P; Dimou M; Solomou E; Loupis T; Zoi K; Giannakopoulou N; Dryllis G; Hatzidavid S; Viniou NA;
Leuk Lymphoma; 2022 Mar; 63(3):729-737. PubMed ID: 34738857
[TBL] [Abstract][Full Text] [Related]
48. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
[TBL] [Abstract][Full Text] [Related]
49. Requirement of MTA1 in ATR-mediated DNA damage checkpoint function.
Li DQ; Ohshiro K; Khan MN; Kumar R
J Biol Chem; 2010 Jun; 285(26):19802-12. PubMed ID: 20427275
[TBL] [Abstract][Full Text] [Related]
50. Prognostic and Immunological Potential of Ribonucleotide Reductase Subunits in Liver Cancer.
Yin X; Jiang K; Zhou Z; Yu H; Yan D; He X; Yan S
Oxid Med Cell Longev; 2023; 2023():3878796. PubMed ID: 36713030
[TBL] [Abstract][Full Text] [Related]
51. De novo deoxyribonucleotide biosynthesis regulates cell growth and tumor progression in small-cell lung carcinoma.
Maruyama A; Sato Y; Nakayama J; Murai J; Ishikawa T; Soga T; Makinoshima H
Sci Rep; 2021 Jun; 11(1):13474. PubMed ID: 34188151
[TBL] [Abstract][Full Text] [Related]
52. High NaCl causes Mre11 to leave the nucleus, disrupting DNA damage signaling and repair.
Dmitrieva NI; Bulavin DV; Burg MB
Am J Physiol Renal Physiol; 2003 Aug; 285(2):F266-74. PubMed ID: 12684226
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of CHK1 sensitizes Ewing sarcoma cells to the ribonucleotide reductase inhibitor gemcitabine.
Goss KL; Koppenhafer SL; Harmoney KM; Terry WW; Gordon DJ
Oncotarget; 2017 Oct; 8(50):87016-87032. PubMed ID: 29152060
[TBL] [Abstract][Full Text] [Related]
54. Chk1 and Chk2 are differentially involved in homologous recombination repair and cell cycle arrest in response to DNA double-strand breaks induced by camptothecins.
Huang M; Miao ZH; Zhu H; Cai YJ; Lu W; Ding J
Mol Cancer Ther; 2008 Jun; 7(6):1440-9. PubMed ID: 18566216
[TBL] [Abstract][Full Text] [Related]
55. ATR, Claspin and the Rad9-Rad1-Hus1 complex regulate Chk1 and Cdc25A in the absence of DNA damage.
Sørensen CS; Syljuåsen RG; Lukas J; Bartek J
Cell Cycle; 2004 Jul; 3(7):941-5. PubMed ID: 15190204
[TBL] [Abstract][Full Text] [Related]
56. Progesterone and DNA damage encourage uterine cell proliferation and decidualization through up-regulating ribonucleotide reductase 2 expression during early pregnancy in mice.
Lei W; Feng XH; Deng WB; Ni H; Zhang ZR; Jia B; Yang XL; Wang TS; Liu JL; Su RW; Liang XH; Qi QR; Yang ZM
J Biol Chem; 2012 May; 287(19):15174-92. PubMed ID: 22403396
[TBL] [Abstract][Full Text] [Related]
57. Expression of ribonucleotide reductase M2 subunit in gastric cancer and effects of RRM2 inhibition in vitro.
Morikawa T; Hino R; Uozaki H; Maeda D; Ushiku T; Shinozaki A; Sakatani T; Fukayama M
Hum Pathol; 2010 Dec; 41(12):1742-8. PubMed ID: 20825972
[TBL] [Abstract][Full Text] [Related]
58. Differential roles of ATR and ATM in p53, Chk1, and histone H2AX phosphorylation in response to hyperoxia: ATR-dependent ATM activation.
Kulkarni A; Das KC
Am J Physiol Lung Cell Mol Physiol; 2008 May; 294(5):L998-L1006. PubMed ID: 18344416
[TBL] [Abstract][Full Text] [Related]
59. Small interfering RNA (siRNA)-mediated silencing of the M2 subunit of ribonucleotide reductase: a novel therapeutic strategy in ovarian cancer.
Zhang M; Wang J; Yao R; Wang L
Int J Gynecol Cancer; 2013 May; 23(4):659-66. PubMed ID: 23466567
[TBL] [Abstract][Full Text] [Related]
60. Role of ATM and the damage response mediator proteins 53BP1 and MDC1 in the maintenance of G(2)/M checkpoint arrest.
Shibata A; Barton O; Noon AT; Dahm K; Deckbar D; Goodarzi AA; Löbrich M; Jeggo PA
Mol Cell Biol; 2010 Jul; 30(13):3371-83. PubMed ID: 20421415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
